Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05937893 · ClinicalTrials.gov registry record · NA
Metabolism in the Human Brain Following Consumption of a Keto-ester in Alcohol Use Disorder (AUD) With Proton Magnetic Resonance Spectroscopic Imaging (MRSI)
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05937893 is a NA study that has completed, run by Yale University. The registered enrollment target is 12 participants.
The verdict
NCT05937893, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of this study is to determine whether BHB levels in the brain will be positively associated with alcohol consumption, due to hypothesized enhancement of BHB transport into the brain.
Interventions
- OTHER Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-08-14 |
| Est. Completion | 2024-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05937893
The ClinicalTrials.gov registry entry for NCT05937893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans is the first listed.
NCT05937893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05937893 about?
NCT05937893 is a clinical study titled "Metabolism in the Human Brain Following Consumption of a Keto-ester in Alcohol Use Disorder (AUD) With Proton Magnetic Resonance Spectroscopic Imaging (MRSI)". The objective of this study is to determine whether BHB levels in the brain will be positively associated with alcohol consumption, due to hypothesized enhancement of BHB transport into the brain.
What is the current status of trial NCT05937893?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2023-08-14. Estimated completion is 2024-05-15.
What interventions are being tested in trial NCT05937893?
The interventions under investigation include: Keto-ester followed by Magnetic Resonance Spectroscopic Imaging (MRSI) scans (OTHER).
Who is sponsoring clinical trial NCT05937893?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.